ALFA stock news
This page provides real-time market news, earnings updates, and company announcements related to Alfa Financial Software Holdings Plc (ALFA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-20 07:13 GMT
Detroit Auto Show sneak peek: Trump and the Big Three dominate the spotlight
101 finance2026-01-13 13:03:33
Stellantis CEO reveals that the recovery strategy features upcoming Jeep models, new Ram pickups, and the comeback of the Hemi V8 engine
101 finance2026-01-22 13:33:13
Stellantis CEO Says Automaker Consolidation Has Strengthened Industry Capabilities
新浪财经2026-02-06 15:29:04
Why Is ImmunityBio Stock Gaining Tuesday?
Finviz2026-02-17 14:48:40
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Bicara Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:34:28
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Finviz2026-02-26 21:03:45
ImmunityBio's IBRX Places 398th in Trade Activity, Achieves 0.10% Increase as Key Study Enhances Optimism
101 finance2026-02-27 00:31:07
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway
Finviz2026-03-03 15:21:51
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-04 13:33:43
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
Freedom Capital Turns Cautious on Tennant (TNC), Downgrades Stock to Hold
Finviz2026-03-09 01:18:49
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
US Stock Alert: Immutep plunges 74.6% pre-market as lung cancer trial terminated due to efficacy and safety data review
格隆汇2026-03-13 09:18:08
ImmunityBio Shares Surge 7.29% on $260M Trading Volume Ranking 454th as Scalable NK-Cell Therapy Validation and Phase 1 Trial Safety Data Drive Investor Optimism
101 finance2026-03-14 01:01:04
An Intriguing Major Investor Is Wagering on a Stellantis Comeback — Is It Worth Your Consideration?
101 finance2026-03-14 09:30:47
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Biohaven’s Taldefgrobep Alfa Hinges on 2026 Phase 2 Obesity Trial: Can It Reroute the Weight-Loss S-Curve?
101 finance2026-03-19 12:03:58
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Bicara Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:34:28
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Finviz2026-02-26 21:03:45
ImmunityBio's IBRX Places 398th in Trade Activity, Achieves 0.10% Increase as Key Study Enhances Optimism
101 finance2026-02-27 00:31:07
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway
Finviz2026-03-03 15:21:51
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-04 13:33:43
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
Freedom Capital Turns Cautious on Tennant (TNC), Downgrades Stock to Hold
Finviz2026-03-09 01:18:49
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
US Stock Alert: Immutep plunges 74.6% pre-market as lung cancer trial terminated due to efficacy and safety data review
格隆汇2026-03-13 09:18:08
ImmunityBio Shares Surge 7.29% on $260M Trading Volume Ranking 454th as Scalable NK-Cell Therapy Validation and Phase 1 Trial Safety Data Drive Investor Optimism
101 finance2026-03-14 01:01:04
An Intriguing Major Investor Is Wagering on a Stellantis Comeback — Is It Worth Your Consideration?
101 finance2026-03-14 09:30:47
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Biohaven’s Taldefgrobep Alfa Hinges on 2026 Phase 2 Obesity Trial: Can It Reroute the Weight-Loss S-Curve?
101 finance2026-03-19 12:03:58
ALFA stock price change
On the last trading day, ALFA stock closed at 152.80 GBP, with a price change of -2.92% for the day.
Trade stock perpsALFA stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more